Reimagining the Mental Health Paradigm

Psilocybin is a naturally occurring chemical found in several species of mushrooms, sometimes referred to as 'magic mushrooms'. It is one of a group of drugs known as 'psychedelics'. After decades of stigma and misunderstanding of psychedelics, dozens of studies are now being conducted at respected institutions that use the highest standards of scientific rigor. 

While the research is still emergent, studies have shown that positive results can come from short courses - even single sessions - of psychedelic-assisted psychotherapy.

Psilocybin, in particular, shows tremendous promise for treating depression, addiction and post-traumatic stress disorder (PTSD). So much so, that the U.S. Food and Drug Administration (FDA) designated psilocybin therapy as a "breakthrough therapy" for depression, suggesting it may be an enormous improvement over already available therapy.

Relevant psilocybin publications and further reading

Read the mainstream media's take on psychedelic research in "The Trip Treatment" - an editorial in the New Yorker.

Follow the latest developments in psilocybin research by following the Psychedelic Research Group at Imperial College London.

Even in non-ideal environments, psilocybin can have profoundly transformative effects. Hear about one journalist's experience with a makeshift psilocybin retreat in Vice.

Journalist and author Michael Pollan describes a beautiful and meaningful psilocybin journey in this excerpt from his book, published in The New York Times.

Book your exploration call

We would like to make sure a ^Lighthouse Retreat is right for you. That is why the first step is to book an exploration call with us.

Please inform us about your preferred date. We will confirm your call via email.